A group of nine countries on Thursday announced they would share H1N1 (swine flu) vaccine supplies with developing nations to protect the world’s poorest from the H1N1 virus, Reuters reports. The U.S. joined Australia, Brazil, France, Italy, New Zealand, Norway, Switzerland, and Britain in the pledge, according to the news service. The new donations add to the 120 million vaccine doses pharmaceutical companies GlaxoSmithKline and Sanofi-Pasteur pledged to WHO.
Access to Health Services
Poor health care, gender inequality, violence and poverty are to blame for Asian-Pacific countries’ failure to significantly reduce maternal and child mortality rates in the region, Noeleen Heyzer, executive secretary of the Economic and Social Commission for Asia and the Pacific (ESCAP), said during the Asia-Pacific Forum on International Conference on Population and Development in Bangkok, VOA News reports.
Also In Global Health News: Tanzania’s Health Care; Polio, Diarrhea In India; ITNs In Nigeria; Health In Sudan
NewsHour Examines Health Care In Tanzania PBS’ NewsHour is airing a three-part series from Sept. 15 â€“ Sept. 17 examining new models of health care delivery in Tanzania, which could provide a model for the rest of the world. The videos examine health worker shortages, the country’s program to fight…
Funding, Health Professional Shortage Could Prevent South Africa From Reaching 2011 ARV Target, Health Minister Says
South Africa’s shortage of health professionals combined with a budget shortfall of over $130 million for the government’s HIV programs could keep the country from reaching its goal of providing 80 percent of the people living with HIV/AIDS in need of treatment with antiretroviral drugs (ARVs) by 2011, South African Health Minister Aaron Motsoaledi said on Tuesday, Reuters reports.
HHS Secretary Kathleen Sebelius announced Tuesday during a House Energy and Commerce Committee hearing that H1N1 (swine flu) vaccines produced by four manufacturers — CSL Ltd., Novartis, Sanofi-Pasteur and Medimmune — had won FDA approval, paving the way for a U.S. large-scale vaccination campaign, the Wall Street Journal reports. The application for GlaxoSmithKline PLC’s vaccine is still being considered.
On Wednesday, the British Medical Journal (BMJ) and the Lancet simultaneously published an editorial and an accompanying letter from 18 doctor association leaders to highlight the need for action at a December U.N. conference on climate change in Copenhagen, Reuters reports (Doyle, 9/16).
Recent findings that a single dose of an H1N1 (swine) flu vaccine offers protection against the virus and anticipation of vaccination programs starting earlier than predicted will increase the number of people worldwide with access to the vaccine and the likelihood health officials may be able to control the spread of the virus, Bloomberg reports.
By offering all children in Africa vaccines that protect against bacterial infections, researchers say the number of deaths among children living with sickle-cell anaemia could be reduced, Reuters reports. An estimated 200,000 children in Africa annually are born with sickle-cell anaemia, a genetic disease “in which red blood cells deform into a sickle shape and cluster, blocking blood flow and causing pain, vulnerability to infections and organ damage.”
In light of the upcoming 7th Global Conference on Health Promotion to be held next month in Nairobi, Kenya, WHO country representative David Okello on Wednesday called upon government leaders to work faster to implement the policies needed to reduce the country’s health burden, the Daily Nation reports.
American Medical News examines the ethical considerations of outsourcing pharmaceutical clinical trials to developing countries. The article highlights how it is less expensive for a drug company to conduct a trial in India, where it runs about $2,000 to track a patient through a trial, compared to the cost in the U.S., which is “10 times more.” The disparities between participants in the two countries in terms of income, education and access to care are “stark” and the playing field “uneven,” writes American Medical News.